The global medical industry experienced a 6% rise in company filings mentions of cloud in Q3 2022 compared with the previous quarter, with the highest share accounted for by ResMed with 43% year-on-year increase, according to GlobalData’s analysis of over 110 medical company filings.

Notably, cloud was one of the most frequently referenced themes in Q3 2022, ranking highest in terms of mentions, ahead of advanced materials and industrial automation, according to GlobalData’s whitepaper on Cloud in Medical Devices – Filings Trends in Q3 2022.

Of the 50 leading companies in the medical industry, ResMed had the greatest increase in references for cloud in Q3 2022, compared with the previous quarter. GlobalData identified 80 cloud -related sentences in the company's filings - 73% of all sentences - and an increase of 95% in Q3 2022 compared with Q2 2022. Idexx Laboratories’s mentions of cloud rose by 33% to 8 and Insulet’s by 150% to 5.

GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cloud in Q3 2022 was 101.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.